Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Medjeral-Thomas

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Immunological Reviews|October 27, 2016
The complement factor H-related proteinsNicholas Medjeral-Thomas, Matthew C Pickering
Molecular Immunology|July 28, 2019
The role of complement in IgA nephropathyAgustin Tortajada, Eduardo Gutierrez, Matthew C Pickering, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2013
Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndromeNicholas Medjeral-Thomas, Stela Ziaj, Marie Condon, et al.
Kidney International|September 27, 2013
A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestryNicholas Medjeral-Thomas, Talat H Malik, Mitali P Patel, et al.
Kidney International Reports|July 9, 2025
Kidney Complement Immunohistochemistry in Thrombotic Microangiopathy SubtypesHannah Beckwith, Nicholas Medjeral-Thomas, Karolina Kwiatkowska, et al.
Ophthalmology|March 10, 2015
Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized DiseaseLavnish Joshi, Anisha Tanna, Stephen P McAdoo, et al.
Clinical Kidney Journal|October 30, 2020
Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progressionMaria Prendecki, Candice Clarke, Nicholas Medjeral-Thomas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 2, 2020
Oral potassium binders: increasing flexibility in times of crisisRakesh Dattani, Peter Hill, Nicholas Medjeral-Thomas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2018
Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitisStephen P McAdoo, Nicholas Medjeral-Thomas, Seerapani Gopaluni, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 21, 2018
Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitisStephen P McAdoo, Nicholas Medjeral-Thomas, Seerapani Gopaluni, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Immunological Reviews|October 27, 2016
The complement factor H-related proteinsNicholas Medjeral-Thomas, Matthew C Pickering
Molecular Immunology|July 28, 2019
The role of complement in IgA nephropathyAgustin Tortajada, Eduardo Gutierrez, Matthew C Pickering, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2013
Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndromeNicholas Medjeral-Thomas, Stela Ziaj, Marie Condon, et al.
Kidney International|September 27, 2013
A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestryNicholas Medjeral-Thomas, Talat H Malik, Mitali P Patel, et al.
Kidney International Reports|July 9, 2025
Kidney Complement Immunohistochemistry in Thrombotic Microangiopathy SubtypesHannah Beckwith, Nicholas Medjeral-Thomas, Karolina Kwiatkowska, et al.
Ophthalmology|March 10, 2015
Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized DiseaseLavnish Joshi, Anisha Tanna, Stephen P McAdoo, et al.
Clinical Kidney Journal|October 30, 2020
Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progressionMaria Prendecki, Candice Clarke, Nicholas Medjeral-Thomas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 2, 2020
Oral potassium binders: increasing flexibility in times of crisisRakesh Dattani, Peter Hill, Nicholas Medjeral-Thomas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2018
Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitisStephen P McAdoo, Nicholas Medjeral-Thomas, Seerapani Gopaluni, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 21, 2018
Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitisStephen P McAdoo, Nicholas Medjeral-Thomas, Seerapani Gopaluni, et al.
Pageof 2